Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL

Armistice Capital, LLC reported a 6.54% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Armistice Capital, LLC reported a 6.54% stake in Rigel Pharmaceuticals, Inc., 1,152,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
6.54%
Shares
1,152,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC6.54%1,152,000
Steven Boyd6.54%1,152,000

Source

View original at SEC

Related